Amarin hit hard as generics loom for fish oil drug VascepaGeneric drugmakers Hikma and Dr Reddy’s Laboratories have won a surprise victory in a US patent lawsuit that Share XAmarin hit hard as generics loom for fish oil drug Vascepahttps://pharmaphorum.com/news/amarin-hit-hard-as-generics-loom-for-fish-oil-drug-vascepa/
UK court imposes safety rules on off-label use of Avastin in wet-AMDBayer has said a new UK court ruling could limit off-label use of Roche’s Avastin in ophthalmology by Share XUK court imposes safety rules on off-label use of Avastin in wet-AMDhttps://pharmaphorum.com/news/uk-appeal-court-upholds-use-of-avastin/
Mallinckrodt proposes $1.6bn deal to settle opioid litigationMallinckrodt is placing a $1.6 billion settlement package on the table as it tries to bring litigation related Share XMallinckrodt proposes $1.6bn deal to settle opioid litigationhttps://pharmaphorum.com/news/mallinckrodt-proposes-1-6bn-deal-to-settle-opioid-litigation/
Jury trial levies $750m damages on J&J over talc and cancerThe jury in a New Jersey trial has awarded $750 million in punitive damages against Johnson & Johnson Share XJury trial levies $750m damages on J&J over talc and cancerhttps://pharmaphorum.com/news/jury-trial-levies-750m-damages-on-jj-over-talc-and-cancer/
Washington State is latest to sue Janssen over opioid marketingWashington State has become the latest to sue Johnson & Johnson over the way it marketed opioid painkillers, Share XWashington State is latest to sue Janssen over opioid marketinghttps://pharmaphorum.com/news/washington-state-is-latest-to-sue-jj-over-opioid-marketing/
Sanofi settles dispute with Genzyme investors over MS drugSanofi has settled a long-running dispute with shareholders in the biotech Genzyme, who claimed the big pharma deliberately Share XSanofi settles dispute with Genzyme investors over MS drughttps://pharmaphorum.com/news/sanofi-settles-dispute-with-genzyme-investors-over-ms-drug/
J&J refutes FDA findings on asbestos in talcJohnson & Johnson has rejected an assertion by the FDA that asbestos had been found in one of Share XJ&J refutes FDA findings on asbestos in talchttps://pharmaphorum.com/news/jj-refutes-fda-findings-on-asbestos-in-talc/
Allergan pays $750m to avoid Alzheimer’s drug lawsuitAllergan has agreed to pay $750 million to settle lawsuits in the US brought by direct purchasers of Share XAllergan pays $750m to avoid Alzheimer’s drug lawsuithttps://pharmaphorum.com/news/allergan-pays-750m-to-avoid-alzheimers-drug-lawsuit/
Major US retailers pull J&J’s talc from shelves over asbestos fearsA trio of major US retailers including Walmart are removing all 22-ounce bottles of Johnson & Johnson’s baby Share XMajor US retailers pull J&J’s talc from shelves over asbestos fearshttps://pharmaphorum.com/news/major-us-retailers-pull-jjs-talc-from-shelves-over-asbestos-fears/
